What Do Dementia in UK Tell Us in 2026?
Dementia is no longer a looming public health crisis on the United Kingdom’s horizon — it has arrived, fully formed, at a scale that now makes it the country’s single most consequential health and social care challenge. The Alzheimer’s Society’s landmark May 2026 “Unlocking the Door” report series, commissioned from Carnall Farrar and drawing on the healthcare records of 26,097 people with dementia across North West London, confirmed what years of prevalence modelling had been predicting: approximately 982,000 people are currently living with dementia in the UK, and the condition is on a trajectory toward 1.4 million by 2040. The ONS data for 2024 confirmed that dementia caused 76,894 deaths in the UK — making it the country’s leading cause of death for the year, ahead of heart disease, cancer, and every other condition. Dementia has been the leading cause of death for UK women since 2011, and the leading cause for men since 2019 — a reality that is slowly, and still inadequately, reshaping the priorities of a health system that was built for an era when people died of different diseases at younger ages.
What makes UK dementia statistics in 2026 particularly urgent is the combination of scale, structural inequality, and systemic underfunding that the data simultaneously reveals. The total economic cost of dementia in the UK is estimated at £42 billion in 2024, with projections pointing toward £90 billion by 2040 — yet only 1.4% of the total healthcare expenditure on dementia is currently spent on diagnosis and treatment. 63% of all dementia costs are borne by patients and their families, not the state — a figure that the Alzheimer’s Society describes as “unacceptable,” and that the May 2026 report series was explicitly designed to change by making the system costs of under-investment legible to policymakers. In a country where one in three people born today will develop dementia in their lifetime, and where one in two of us will be affected either by developing the condition or caring for someone who has it, dementia statistics in 2026 are not a specialist health topic — they are facts about every family in Britain.
Interesting Facts About Dementia in the UK in 2026
| # | Fact | Key Figure / Source |
|---|---|---|
| 1 | 982,000 people are currently living with dementia in the UK — close to one million | Dementia Statistics Hub / Alzheimer’s Society (Carnall Farrar 2024); confirmed 2026 |
| 2 | UK dementia cases are projected to reach 1.4 million by 2040 | Alzheimer’s Society / Dementia Statistics Hub, 2026 |
| 3 | 76,894 people died from dementia in the UK in 2024 — the #1 leading cause of death | Alzheimer’s Society, April 2026; ONS data 2024 |
| 4 | 48,915 women and 27,979 men died from dementia in the UK in 2024 | Alzheimer’s Research UK, December 2025 |
| 5 | Dementia has been the leading cause of death for women since 2011 and for the overall UK population since 2019 | Alzheimer’s Research UK; Dementia UK, January 2026 |
| 6 | The total economic cost of dementia in the UK is £42 billion in 2024, projected to rise to £90 billion by 2040 | Alzheimer’s Society / Carnall Farrar Economic Impact Report (2024); Dementia Statistics Hub, 2026 |
| 7 | 63% of all dementia costs are borne by patients and their families — not the NHS or state | Alzheimer’s Society / Carnall Farrar, October 2024 |
| 8 | 510,339 patients had a recorded dementia diagnosis in England on 28 February 2026 — only 66.1% of estimated cases aged 65+ | NHS England Primary Care Dementia Data, February 2026 |
| 9 | Around 40% of those aged 65+ thought to have dementia do not have a formal diagnosis | Dementia Statistics Hub, 2026 |
| 10 | 25% of all acute NHS hospital beds are occupied by people with dementia | NHS England / Healthcare Quality Improvement Partnership, 2026 |
| 11 | Alzheimer’s disease accounts for 44.6% of all dementia diagnoses in England — the most common subtype | NHS England December 2023 data (latest diagnostic breakdown) |
| 12 | One in three people born today will develop dementia in their lifetime; one in two will be affected as a patient or carer | Dementia UK, January 2026; Alzheimer’s Society |
| 13 | The annual per-person cost of severe dementia is £80,500 — nearly 3× the cost of mild dementia at £28,700 | Alzheimer’s Society / Carnall Farrar, 2024 |
| 14 | Residential dementia care averages £1,343 per week — approximately £45/week more than standard residential care | Carehome.co.uk, 2026; Unique Care elderly care statistics, 2026 |
| 15 | Only 1.4% of total dementia healthcare expenditure is currently spent on diagnosis and treatment — despite strong evidence of benefits | Alzheimer’s Society / Carnall Farrar, May 2026 |
Source: Alzheimer’s Society / Carnall Farrar Economic Impact of Dementia Reports (October 2024; May 2026); NHS England Primary Care Dementia Data (February 2026); Dementia Statistics Hub 2026; Alzheimer’s Research UK (December 2025); Dementia UK (January 2026); ONS 2024 Mortality Data; NHS England Dementia Programme and Preparation Paper; Unique Care UK Elderly Care Statistics 2026; Carehome.co.uk residential care pricing 2026; Healthcare Quality Improvement Partnership
The 15 facts above position UK dementia in 2026 as a condition that has achieved the grim distinction of sitting at the top of the mortality league table while simultaneously receiving some of the least proportionate investment of any major killer. The 76,894 deaths from dementia in 2024 — nearly 49,000 of them women — is a number that reflects both the genuine lethality of the condition and the UK’s ageing demographic reality: as the post-war generation moves through its eighties, dementia’s death toll will continue to climb regardless of any changes to prevention or care, because the people who will develop the condition in the next decade have already been born. What makes the £42 billion annual cost particularly striking is its composition: it is not primarily an NHS bill but a family bill, with 63 pence of every £1 spent on dementia in the UK coming from the pockets and unpaid hours of patients and their families rather than from the public purse.
The diagnosis gap embedded in the February 2026 NHS England data is one of the most consequential single statistics in this report. Only 510,339 people had a recorded dementia diagnosis in England as of February 2026 — representing just 66.1% of the estimated number of people aged 65 and over who are thought to have the condition. One in three people with dementia in the UK does not have a diagnosis — meaning they are navigating a terminal progressive illness without access to the support, care planning, medication management, and clinical trials that a diagnosis would unlock. This is not a marginal gap at the edges of the healthcare system; it is a structural failure that falls hardest on the most isolated, most vulnerable, and least likely to self-advocate — and that the Alzheimer’s Society’s May 2026 report series described as leaving people to “face dementia alone.”
UK Dementia Prevalence by Type & Demographic in 2026 | Clinical Breakdown
UK Dementia — Prevalence by Type (2026 Data)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Alzheimer's disease ████████████████████████████████████████ 60–70% of all cases
Vascular dementia ████████████████████████ 10–20% of cases
Dementia with Lewy bodies ████████████████████ 5–10% of cases
Frontotemporal dementia ████████████████ Under 5% of cases
Mixed / Other dementias ████████████████████ 10–20% of cases
Women as % of all cases ████████████████████████████████████████ ~65–66%
Young onset (under 65) ████████████████████ 70,800 in UK
Black adults: higher risk █████████████████████████████████ 20%+ above UK avg
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Scale: Each █ ≈ relative proportional share
| Dementia Type / Group | Prevalence / Key Stat | Key Characteristic |
|---|---|---|
| Alzheimer’s disease | 60–70% of all UK dementia cases; 44.6% of recorded diagnoses (NHS England) | Most common; progressive amyloid/tau pathology; no NHS-approved disease-modifying treatment available |
| Vascular dementia | 10–20% of cases | Caused by reduced blood flow to the brain; strongly linked to cardiovascular risk factors |
| Dementia with Lewy bodies (DLB) | 5–10% of cases | Includes hallucinations, fluctuating cognition, Parkinsonism; frequently misdiagnosed |
| Frontotemporal dementia (FTD) | Under 5% | More common in younger-onset cases; personality/behaviour changes before memory symptoms |
| Mixed dementia | 10–20% | Often Alzheimer’s + vascular; common in oldest patients |
| Women | ~65–66% of all UK dementia cases | Driven by greater longevity; dementia has been #1 cause of death for women since 2011 |
| Young-onset dementia (under 65) | 70,800 people in the UK | Often misdiagnosed; working-age population; poor access to age-appropriate support |
| Black adults | Over 20% higher incidence than UK average | Higher rates of hypertension, diabetes, cardiovascular risk; plus diagnostic barriers |
| Black/Asian minority communities | 25,000+ older people in England and Wales; expected to double by 2026 | Often face delayed diagnosis and access barriers; steepest increase in South Asian communities |
| Average age at diagnosis | ~80 years | Prevalence rises sharply after 75; in the 85–89 age group prevalence is highest |
| Average survival post-diagnosis | 4–8 years | Varies significantly by age at diagnosis, type, and comorbidities |
Source: Dementia Hub UK (December 2025); NHS England Dementia Programme Paper; Alzheimer’s Society; NHS England RightCare Dementia Scenario; Dementia UK (January 2026); PMC UK EHR study (4.3 million individuals); Alzheimer’s Research UK; Dementia Statistics Hub 2026
The dementia type breakdown for the UK in 2026 is dominated by Alzheimer’s disease, which represents between 60 and 70% of all cases and whose trajectory is now the primary driver of the UK’s long-term dementia projections. The 44.6% specifically recorded as Alzheimer’s disease in NHS England’s diagnostic data slightly understates the true prevalence because mixed dementia — which frequently combines Alzheimer’s pathology with vascular changes — makes up a further 10–20% of cases and typically involves the same underlying amyloid and tau accumulation processes. The clinical significance of these distinctions in 2026 is sharpened by the fact that two new disease-modifying Alzheimer’s treatments (lecanemab and donanemab) were licensed in the UK in 2024 but were not approved for NHS use — a regulatory decision that has generated intense debate about the UK’s readiness to benefit from a new generation of dementia therapies.
The young-onset figure of 70,800 people under 65 living with dementia in the UK in 2026 captures a population that is systematically underserved by a care and support system designed around older patients. Young-onset dementia is frequently misdiagnosed, with patients initially presenting symptoms being redirected through mental health, neurology, or occupational health pathways before the correct diagnosis is reached — often years after symptoms begin. The demographic and economic consequences of working-age dementia are distinct and severe: these individuals may have dependent children, active mortgages, career responsibilities, and financial obligations that an older patient would not — and the support infrastructure available to them is markedly less developed than for older patients. The doubling of older Black and ethnic minority people with dementia in England and Wales by 2026 cited by NHS England represents one of the most urgent equity challenges in UK dementia care, compounded by documented barriers to timely diagnosis in these communities.
UK Dementia Economic & Care Costs in 2026 | Financial Breakdown
UK Dementia Total Annual Costs — Breakdown (2024 Base, Projections to 2040)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Total annual cost (2024) ████████████████████████████████████████ £42 billion
Families / patients bear ████████████████████████████████████████ 63% (£26.5B)
Social care costs ████████████████████████████████████████ ~40% of total
Unpaid care costs ████████████████████████████████████████ ~50% of total
NHS / formal care ████████████████████████████████████████ ~10% of total
Diagnosis / treatment spend ██ Only 1.4% of health spend
Severe dementia annual cost ████████████████████████████████████████ £80,500/person/yr
Mild dementia annual cost ████████████████████ £28,700/person/yr
Projected cost by 2040 ████████████████████████████████████████ £90 billion
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Scale: Each █ ≈ relative magnitude
| Cost Category | Figure | Key Context |
|---|---|---|
| Total UK dementia economic cost (2024) | £42 billion | Forecast to reach £90 billion by 2040; almost 2% of GDP by 2030 |
| Share borne by patients and families | 63% (~£26.5 billion) | “Unacceptable” burden — Alzheimer’s Society, 2026 |
| Social care costs | ~40% of total | Largest formal system cost; residential and nursing home care dominant |
| Unpaid care | ~50% of total | The invisible economic foundation of dementia care in the UK |
| NHS / formal health care | ~10% of total | Surprisingly small share given hospital utilisation |
| Diagnosis and treatment spending | Only 1.4% of total healthcare expenditure on dementia | Despite strong evidence of savings from early diagnosis |
| Annual cost — mild dementia | £28,700 per person | Alzheimer’s Society / Carnall Farrar |
| Annual cost — moderate dementia | £42,900 per person | Alzheimer’s Society / Carnall Farrar |
| Annual cost — severe dementia | £80,500 per person | Nearly 3× the cost of mild dementia |
| Residential dementia care weekly | £1,343 per week | ~£69,836 per year; ~£45/week premium over standard care |
| Care staff replacement costs | £3 billion per year | Care England estimate; massive workforce turnover burden |
| NHS dementia diagnosis investment | Insufficient for demand | 33% of dementia patients in England had no post-diagnostic follow-up within 12 months |
| Nearly 50% fully self-funding | ~50% of people fully fund their own residential and nursing care | Private wealth determines care quality in absence of state support |
| Projected cost trajectory | £42B (2024) → £57B by 2030 → £90B by 2040 | Alzheimer’s Society Briefing, UK Parliament Written Evidence |
Source: Alzheimer’s Society / Carnall Farrar Economic Impact Reports (2024; May 2026); Dementia Statistics Hub Economic Impact Page (2026); Alzheimer’s Society Parliamentary Briefing (2025); UK Parliament Health and Social Care Committee Written Evidence; Care England via Alzheimer’s Society; Carehome.co.uk 2026; NHS England Dementia Programme
The financial architecture of dementia care in the UK in 2026 is one of the most ethically troubling structural features of the country’s health and social care system, and the data makes clear exactly why. When 63% of the £42 billion annual cost is borne by patients and their families — and when that figure is composed of roughly equal parts social care payments and unpaid care hours — the picture that emerges is of a state that has functionally outsourced the delivery and financing of care for its most vulnerable citizens to those citizens’ families. The 50% share attributed to unpaid care is particularly striking: it means that the UK’s dementia care infrastructure is built on approximately £21 billion worth of work performed annually by family members and other unpaid carers — work that is invisible in national accounts, performed disproportionately by women, and accompanied by well-documented impacts on the physical and mental health of those providing it.
The per-person cost escalation from £28,700 for mild dementia to £80,500 for severe dementia is the most powerful economic argument for early diagnosis and intervention that the UK’s dementia data contains. Keeping a person in the earlier stages of dementia for longer — through better diagnosis, medication management, and lifestyle support — is not just clinically desirable; it is fiscally rational. The 1.4% of dementia healthcare spending going to diagnosis and treatment represents one of the most glaring misallocations in the UK’s health system: the very interventions that have the greatest potential to reduce the £21 billion unpaid care burden, delay residential care admission, and reduce unplanned hospital admissions are receiving a share of the budget so small it barely registers. The Alzheimer’s Society’s “Unlocking the Door” series, published in May 2026, was designed precisely to make this economic case as clearly and evidentially as possible to a government facing NHS reform pressure and social care crisis simultaneously.
UK Dementia Carers Statistics in 2026 | Unpaid Care Burden
UK Dementia Unpaid Carers — Key Statistics (2026)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Total unpaid dementia carers ████████████████████████████████████████ ~700,000
Female carers (share) ████████████████████████████████████████ ~2 in 3 (66%)
Carers spending 100+ hrs/week ████████████████████████████████████████ 1 in 3 report this
Annual unpaid care hours ████████████████████████████████████████ 1.1 billion hours
Need for unpaid care by 2040 ████████████████████████████████████████ +43% increase projected
Value of unpaid care annually ████████████████████████████████████████ ~£21 billion (50% of £42B total)
Carers at risk: stress/depression████████████████████████████████████████ Elevated vs non-carers
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Carer Statistic | Figure | Source |
|---|---|---|
| Estimated number of unpaid dementia carers (UK) | ~700,000 | UK Parliament Health & Social Care Committee |
| Female share of unpaid dementia carers | ~two-thirds (66%) | Age UK Parliamentary Briefing, June 2025 |
| Carers spending 100+ hours per week | 1 in 3 unpaid dementia carers report this | Alzheimer’s Society / Carnall Farrar, 2024 |
| Annual unpaid care hours provided | 1.1 billion hours per year | NHS England RightCare Dementia Scenario |
| Unpaid care’s share of total dementia cost | ~50% of £42 billion total | Alzheimer’s Society / Carnall Farrar |
| Projected increase in unpaid care need (by 2040) | +43% | Alzheimer’s Society, 2024 |
| Health risk to unpaid carers | Elevated rates of stress, depression, and other health complications | Brodaty et al., cited by NHS England |
| Carer’s Allowance claimants (UK, August 2024) | 1.4 million | Department for Work and Pensions; Health Foundation, 2025 |
| Local authority support recipients | Just over 300,000 in 2023/24 | Health Foundation, 2025 |
| 76,000 more people in residential care by 2040 | Projected 76,000 in residential homes + 30,000 in nursing homes more than today | Alzheimer’s Society / Carnall Farrar |
| Care staff replacement costs annually | £3 billion | Care England, cited Alzheimer’s Society |
| Social care staff recruitment challenge | Over 50% of providers report difficulty recruiting | Alzheimer’s Society Carnall Farrar Report |
Source: Age UK Parliamentary Briefing on Dementia Care (June 2025); Alzheimer’s Society / Carnall Farrar Reports (2024; May 2026); NHS England RightCare Dementia Scenario; Health Foundation: Unpaid Care Realities (2025); UK Parliament Health & Social Care Committee Report; Care England; DWP Carer’s Allowance Data
The unpaid carer data is the human reality behind every economic figure in this article, and it describes a level of personal sacrifice that the UK’s social care system has been quietly depending on for decades. 700,000 unpaid dementia carers — two thirds of them women — are providing 1.1 billion hours of care annually, much of it around the clock: one in three reports spending more than 100 hours a week caring for a person with dementia. One hundred hours per week means effectively full-time caregiving with little sleep, no salary, and often no respite. The health consequences of this level of sustained care are well-documented: elevated rates of depression, anxiety, physical illness, and social isolation among dementia carers represent a secondary health crisis that sits alongside the primary one, and that the health system’s own data consistently underestimates.
The +43% projected increase in the need for unpaid care by 2040 — driven by the 1.4 million case projection — makes the current carer supply challenge look modest by comparison with what is coming. At the same time, the care workforce crisis — where more than 50% of social care providers already report difficulty recruiting and the cost of replacing staff across the sector runs to £3 billion per year — is projected to intensify as demand accelerates. This convergence of demographic inevitability, workforce shortage, and chronically underfunded state provision describes a care system that is structurally misaligned with the challenge it faces, and that is absorbing the gap through the hidden mechanism of family sacrifice that the economic data only partially captures. The May 2026 Alzheimer’s Society report series makes the case that this trajectory is neither inevitable nor affordable — and that earlier diagnosis, better-supported carers, and modest investment in the right points of the care pathway would generate system-level savings that dramatically exceed their cost.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
